본문바로가기

자료 카테고리

전체 1
도서자료 0
학위논문 1
연속간행물·학술기사 0
멀티미디어 0
동영상 0
국회자료 0
특화자료 0

도서 앰블럼

전체 (0)
일반도서 (0)
E-BOOK (0)
고서 (0)
세미나자료 (0)
웹자료 (0)
전체 (1)
학위논문 (1)
전체 (0)
국내기사 (0)
국외기사 (0)
학술지·잡지 (0)
신문 (0)
전자저널 (0)
전체 (0)
오디오자료 (0)
전자매체 (0)
마이크로폼자료 (0)
지도/기타자료 (0)
전체 (0)
동영상자료 (0)
전체 (0)
외국법률번역DB (0)
국회회의록 (0)
국회의안정보 (0)
전체 (0)
표·그림DB (0)
지식공유 (0)

도서 앰블럼

전체 1
국내공공정책정보
국외공공정책정보
국회자료
전체 ()
정부기관 ()
지방자치단체 ()
공공기관 ()
싱크탱크 ()
국제기구 ()
전체 ()
정부기관 ()
의회기관 ()
싱크탱크 ()
국제기구 ()
전체 ()
국회의원정책자료 ()
입법기관자료 ()

검색결과

검색결과 (전체 1건)

검색결과제한

열기
논문명/저자명
Anti-and pro-apoptotic roles of human RAD51 = 사람 RAD51의 세포 사멸 과정 저해와 촉진 기능 / 이남식 인기도
발행사항
대전 : 배재대학교 대학원, 2004.2
청구기호
TD 574.192 ㅇ621a
형태사항
xiv, 137 p. ; 26 cm
자료실
전자자료
제어번호
KDMT1200418184
주기사항
학위논문(박사) -- 배재대학교 대학원, 생화학, 2004.2
원문
미리보기

목차보기더보기

표제지

목차

1. INTRODUCTION 19

1.1. Human RAD51 19

1.1.1. RAD51 in a repair mechanism 19

1.1.2. Interacting proteins with RAD51 22

1.1.3. Modification and expression of RAD51 in tumor cells 24

1.1.4. RAD51 in apoptosis 25

1.2. ASK1 as an apoptotic inducer 27

1.3. ABL-tyrosine kinase as a RAD51 modifier 30

1.4. Apoptosis as a "fail-safe" mechanism 33

1.5. The aim of this study 35

2. MATERIALS AND METHODS 38

2. 1. Construction of epitope-tagged RAD51 clones in mammalian expression vectors 38

2. 2. Construction of deletion and point mutants for RAD51 in mammalian expression vectors 38

2. 3. Construction of GST-tagged ASK1 expression clones 39

2. 4. In vitro binding assay for RAD51 and ASK1 40

2. 5. Cell culture and transfection 40

2. 6. Antibodies for the experimentation 41

2. 7. Immuno-fluorescence analysis using a fluorescence microscopy 42

2. 8. Subcellular fractionation and localization 43

2. 9. Co-immunoprecipitation 43

2. 10. Immunoblotting 44

2. 11. Caspase activity assay 45

2. 12. Morphological analysis of cells 46

2. 13. In vitro JNK and p38 kinase assays 46

2. 14. ASK1 kinase assay 47

2. 15. Constructions of Flag-tagged MAPK and dominant negative clones in mammalian expression vectors 48

2. 16. Inhibition of BCR/ABL tyrosine Kinase 49

3. RESULTS 50

3.1. Interaction of RAD51 with ASK1 50

3.1.1. RAD51 interacts to ASK1 in HEK 293 and 293T cells 50

3.1.2. RAD51 and ASK1 interaction occurs in the cytoplasm of HEK 293 cells 50

3.1.3. RAD51 interaction regions within ASK1 55

3.2. Inhibition of ASK1 kinase activity by RAD51 58

3.2.1. Direct inhibition of ASK1 kinase activity by RAD51 58

3.2.2. MEKK1 was not inhibited by RAD51 58

3.2.3. Down-regulation of ASK1 downstream MAP-Kinases activities by RAD51, in vitro 62

3.2.4. Inactivation of ASK1 downstream MAP kinases by RAD51 co-expression, in vivo 67

3.2.5. Dose-dependent ASK1 inhibition of RAD51 67

3.3. Inhibition of ASK1-mediated apoptosis 71

3.3.1. Inhibition of TNF-α induced apoptosis by RAD51 71

3.3.2. Effect of RAD51 on Caspase 3 activity stimulated by ASK1 expression 74

3.3.3. Inhibition of ASK1 dimerization by RAD51 78

3.3.4. RAD51 blocked JNK activation caused by TNF-α treatment 78

3.3.5. Reduced interaction of RAD51 with ASK1 after TNF-α treatment in 293 cell 82

3.4. Requirement of phosphorylation at Y315 of RAD51 forASK1 inhibition 84

3.4.1. Effects of RAD51 tyrosine mutants on C-Jun N-terminal kinase activation by ASK1 84

3.4.2. Effect of mutations on the conserved Walker type domains of RAD51 in ASK1 inhibition 87

3.4.3. Interactions of RAD51 mutants with GST-tagged ASK1 deletion series 89

3.4.4. RAD51 phosphorylation was decreased via ABL tyrosine kinase inactivation by STI571 (Gleevec) in HEK 293 cells 89

3.4.5. Effect of STI571 on ASK1 inactivation by RAD51 97

3.5. Cleaved RAD51 by Caspase-3 triggers apoptosis : a "Fail-Safe" mechanism 103

3.5.1. RAD51 was cleaved during apoptosis induced by various stress signals 103

3.5.2. Expression of RAD51 truncation mutants in HEK 293 cells 103

3.5.3. Localization of RAD51 truncation mutants 106

3.5.4. Activation of Jun N-terminal kinase by the RAD51 C-terminus expressed in HEK 293 cells 106

3.5.5. Caspase activation by the RAD51 C-terminus in HEK 293 cells 109

3.5.6. Apoptosis induced by the C-terminus of RAD51 in HEK 293 cells was independent with ASK1 and JNK activations 109

3.5.7. Mitochondria independency in apoptosis induced by the C-terminus of RAD51 in HEK 293 cells 113

3.5.8. Caspase-3 inhibitors blocked cell death induced by expression of the RA51-C terminus 118

4. DISCUSSION 121

5. REFERENCES 128

6. ABSTRACT IN KOREAN 138

7. ACKNOWLEDGEMENT 141

8. APPENDIX 142

Figure 1.1. Homologous recombination by RAD51 20

Figure 1.2. Various proteins interacting with RAD51 23

Figure 1.3. Phosphorylation of RAD51 by various kinases 26

Figure 1.4. Overview in ASK1 induced apoptosis 28

Figure 1.5. MAP Kinase cascade modules 29

Figure 1.6. Generation and Reaction of BCR/ABL 32

Figure 1.7. Structure and the reaction mechanism of STI 34

Figure 1.8. The relation of DNA repair and apoptosis 36

Figure 3.1. Interactions of RAD51 and ASK1 in HEK 293 and 293T cells 51

Figure 3.2. Localization of ASK1 and RAD51 proteins in HEK 293 cells 53

Figure 3.3. RAD51 interaction regions in ASK1 56

Figure 3.4. Inhibition of ASK1 kinase activity by RAD51 59

Figure 3.5. Inhibition of ASK1 but not MEKK1 by RAD51 60

Figure 3.6. In vitro kinase assays for the effect of RAD51 and ASK1 on JNK activity 63

Figure 3.7. In vitro kinase assays for the effect of RAD51 and ASK1 on p38 kinase activity 65

Figure 3.8. Inactivation of ASK1-downstream MAP kinases byRAD51 co-expression, in vivo 68

Figure 3.9. Dose-dependent ASK1 inhibition by RAD51 70

Figure 3.10. Inhibition of TNF-α induced apoptosis by RAD 72

Figure 3.11. Inhibitory effect of RAD51 on Caspase-3 activity activated by ASK1 expression 75

Figure 3.12. Inhibition of ASK1 dimerization by RAD51 79

Figure 3.13. Down-regulation of JNK activation after treatments of certain DNA damaging agents by RAD51 80

Figure 3.14. Reduced interaction of RAD51 with ASK1 after TNF-α treatment in 293 cells 83

Figure 3.15. Effects of the RAD51 tyrosine mutants on JNK activation by ASK1 over-expression 85

Figure 3.16. Effects of RAD51 tyrosine mutations on Caspase-3 activation by ASK1 88

Figure 3.17. Effects of the RAD51 mutations in the Walker type domains on JNK activation by ASK1 90

Figure 3.18. Dephosphorylation of RAD51 after STI571 treatment via ABL-inactivation in 293 cells 95

Figure 3.19. Effect of STI571 on ASK1 inactivation by RAD 99

Figure 3.20. Effect of STI571 in ASK1 inactivation by RAD315 tyrosine mutants (Y315F) 101

Figure 3.21. Hypothetical scheme of ASK1 inhibition by RAD ; in BCR/ABL positive cells 102

Figure 3.22. Endo-RAD51 cleavage by stress signals 104

Figure 3.23. Induction of apoptosis by the RAD51 C-terminus 107

Figure 3.24. Localization of RAD51 truncation mutants 108

Figure 3.25. Activations of JNK and p38 kinases by the RAD51 C- and N-terminal truncation mutants 110

Figure 3.26. Various caspase activities after over-expression of the RAD51-C terminus in HEK 293 cells 112

Figure 3.27. JNK and Caspase-3 activation by the RAD51-C terminus with co-expression of dominant negative forms of JNK upstream MAP kinases 114

Figure 3.28. Cell morphology after transient transfection of the RAD51 C-terminus with/without coexpression of dominant negative forms of MAPKs 116

Figure 3.29. Requirement of Caspase-3 in cell death induced by the RAD51 C-terminus 117

Figure 3.30. The caspase-3 inhibitors including ZVAD-fmk blocked cell death by overexpression of the RA51-C terminus 119

Figure 4.1. Scheme of anti-and pro-apoptotic roles of RAD 127

Table 1. The RAD51 paralogs 21

Table 2. Summary of the effects of RAD51 mutants in ASK1 inhibition 92

Table 3. Summary of in vitro binding assays for various RAD51 mutants and ASK1 93

권호기사보기

권호기사 목록 테이블로 기사명, 저자명, 페이지, 원문, 기사목차 순으로 되어있습니다.
기사명 저자명 페이지 원문 기사목차
연속간행물 팝업 열기 연속간행물 팝업 열기